BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 31391007)

  • 21. Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer.
    Liu Y; Kheradmand F; Davis CF; Scheurer ME; Wheeler D; Tsavachidis S; Armstrong G; Simpson C; Mandal D; Kupert E; Anderson M; You M; Xiong D; Pikielny C; Schwartz AG; Bailey-Wilson J; Gaba C; De Andrade M; Yang P; Pinney SM; ; Amos CI; Spitz MR
    J Thorac Oncol; 2016 Jan; 11(1):52-61. PubMed ID: 26762739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes.
    Walsh MF; Ritter DI; Kesserwan C; Sonkin D; Chakravarty D; Chao E; Ghosh R; Kemel Y; Wu G; Lee K; Kulkarni S; Hedges D; Mandelker D; Ceyhan-Birsoy O; Luo M; Drazer M; Zhang L; Offit K; Plon SE
    Hum Mutat; 2018 Nov; 39(11):1542-1552. PubMed ID: 30311369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and clinical application of an integrative genomic approach to personalized cancer therapy.
    Uzilov AV; Ding W; Fink MY; Antipin Y; Brohl AS; Davis C; Lau CY; Pandya C; Shah H; Kasai Y; Powell J; Micchelli M; Castellanos R; Zhang Z; Linderman M; Kinoshita Y; Zweig M; Raustad K; Cheung K; Castillo D; Wooten M; Bourzgui I; Newman LC; Deikus G; Mathew B; Zhu J; Glicksberg BS; Moe AS; Liao J; Edelmann L; Dudley JT; Maki RG; Kasarskis A; Holcombe RF; Mahajan M; Hao K; Reva B; Longtine J; Starcevic D; Sebra R; Donovan MJ; Li S; Schadt EE; Chen R
    Genome Med; 2016 Jun; 8(1):62. PubMed ID: 27245685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations.
    Kuzbari Z; Bandlamudi C; Loveday C; Garrett A; Mehine M; George A; Hanson H; Snape K; Kulkarni A; Allen S; Jezdic S; Ferrandino R; Westphalen CB; Castro E; Rodon J; Mateo J; Burghel GJ; Berger MF; Mandelker D; Turnbull C
    Ann Oncol; 2023 Mar; 34(3):215-227. PubMed ID: 36529447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline PARP4 mutations in patients with primary thyroid and breast cancers.
    Ikeda Y; Kiyotani K; Yew PY; Kato T; Tamura K; Yap KL; Nielsen SM; Mester JL; Eng C; Nakamura Y; Grogan RH
    Endocr Relat Cancer; 2016 Mar; 23(3):171-9. PubMed ID: 26699384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery analysis of TCGA data reveals association between germline genotype and survival in ovarian cancer patients.
    Braun R; Finney R; Yan C; Chen QR; Hu Y; Edmonson M; Meerzaman D; Buetow K
    PLoS One; 2013; 8(3):e55037. PubMed ID: 23555554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligogenic germline mutations identified in early non-smokers lung adenocarcinoma patients.
    Renieri A; Mencarelli MA; Cetta F; Baldassarri M; Mari F; Furini S; Piu P; Ariani F; Dragani TA; Frullanti E
    Lung Cancer; 2014 Aug; 85(2):168-74. PubMed ID: 24954872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Genomics medicine and oncology].
    Michielin O; Coukos G
    Praxis (Bern 1994); 2014 May; 103(10):591-6. PubMed ID: 24800772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing.
    Helman E; Lawrence MS; Stewart C; Sougnez C; Getz G; Meyerson M
    Genome Res; 2014 Jul; 24(7):1053-63. PubMed ID: 24823667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Large-Scale Exome-Wide Association Study Identifies Novel Germline Mutations in Lung Cancer.
    Shen S; Li Z; Jiang Y; Duan W; Li H; Du S; Esteller M; Shen H; Hu Z; Zhao Y; Christiani DC; Chen F
    Am J Respir Crit Care Med; 2023 Aug; 208(3):280-289. PubMed ID: 37167549
    [No Abstract]   [Full Text] [Related]  

  • 31. The Clinical Genome and Ancestry Report: An interactive web application for prioritizing clinically implicated variants from genome sequencing data with ancestry composition.
    Lee IH; Negron JA; Hernandez-Ferrer C; Alvarez WJ; Mandl KD; Kong SW
    Hum Mutat; 2020 Feb; 41(2):387-396. PubMed ID: 31691385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study.
    Hutchcraft ML; Zhang S; Lin N; Pickarski JC; Belcher EA; Wei S; Bocklage T; Miller RW; Villano JL; Cavnar MJ; Kim J; Arnold SM; Ueland FR; Kolesar JM
    JCO Precis Oncol; 2024 Jan; 8():e2300266. PubMed ID: 38295319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical relevance of cancer genome sequencing.
    Ku CS; Cooper DN; Roukos DH
    World J Gastroenterol; 2013 Apr; 19(13):2011-8. PubMed ID: 23599619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management.
    McGee RB; Oak N; Harrison L; Xu K; Nuccio R; Blake AK; Mostafavi R; Lewis S; Taylor LM; Kubal M; Ouma A; Hines-Dowell SJ; Cheng C; Furtado LV; Nichols KE
    Clin Cancer Res; 2023 Apr; 29(7):1243-1251. PubMed ID: 36693186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haplotype-resolved germline and somatic alterations in renal medullary carcinomas.
    Tan KT; Kim H; Carrot-Zhang J; Zhang Y; Kim WJ; Kugener G; Wala JA; Howard TP; Chi YY; Beroukhim R; Li H; Ha G; Alper SL; Perlman EJ; Mullen EA; Hahn WC; Meyerson M; Hong AL
    Genome Med; 2021 Jul; 13(1):114. PubMed ID: 34261517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer genomics and inherited risk.
    Stadler ZK; Schrader KA; Vijai J; Robson ME; Offit K
    J Clin Oncol; 2014 Mar; 32(7):687-98. PubMed ID: 24449244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optical genome mapping identifies structural variants in potentially new cancer predisposition candidate genes in pediatric cancer patients.
    Wagener R; Brandes D; Jung M; Huetzen MA; Bergmann AK; Panier S; Picard D; Fischer U; Jachimowicz RD; Borkhardt A; Brozou T
    Int J Cancer; 2024 Feb; 154(4):607-614. PubMed ID: 37776287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline potential should not be overlooked for cancer variants identified in tumour-only somatic mutation testing.
    Al-Shinnag M; Cheong PL; Goodwin A; Trent R; Yu B
    Pathology; 2024 Jun; 56(4):468-472. PubMed ID: 38627125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic sequencing in cancer.
    Tuna M; Amos CI
    Cancer Lett; 2013 Nov; 340(2):161-70. PubMed ID: 23178448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exome sequencing of affected duos and trios uncovers PRUNE2 as a novel prostate cancer predisposition gene.
    Cardoso M; Maia S; Brandão A; Sahasrabudhe R; Lott P; Belter N; Carvajal-Carmona LG; Paulo P; Teixeira MR
    Br J Cancer; 2023 Apr; 128(6):1077-1085. PubMed ID: 36564567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.